Search clinical trials for: Primary Hyperoxaluria Type 3

Total 90471 results

Rabin Medical Center
Omega 3 Galilee

Recruiting

The Effect of Omega Galil Hazelnut Chocolate Spread "O'Sweet Spread" With 80% Reduced Sucrose on Glucose Response of People With TID

Type1diabetes

Israel
3-C Institute for Social Development

Completed

Mobile Technology & Online Tools to Track Adherence in Chronic Illness Patients (OMMS)

Diabetes Mellitus, Type 1

United States
Apellis Pharmaceuticals, Inc.

Available

C3G/Primary IC-MPGN EAP

C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...

United States
Kathmandu University School of Medical Sciences

Completed

Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal

Cervical Cancer | Screening | Stigma

Nepal
Endobar Solutions LLC
Na Homolce Hospital; OB KLINIKA a.s. Pod Krejcárkem 975 Praha 3 - Žižkov Tel... and other collaborators

Completed

The Lowering Weight in Severe Obesity by Embolization of the Gastric Artery Trial (LOSEIT)

Obesity, Morbid

Czechia
LEO Pharma

Completed

Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100

Psoriasis Vulgaris

France
VANBIERVLIET

Completed

Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS (PICORE)

Pancreatic Tumor | Endoscopic Ultrasonography | Fine Needle Aspiration

France
Therapeutics, Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis

Tinea Pedis | Tinea Cruris

United States
ASLAN Pharmaceuticals

Completed

A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States, Australia, Singapore
University Hospital, Strasbourg, France

Unknown

Long Term Follow up of Patients Under 5 Years of Age With High Grade Glioma Diagnosed in France Between 1990 and 2015 (GlioUnder5)

Glioma

France
Mahidol University
Bayer; Chulalongkorn University; Bumrungrad International Hospital

Completed

Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)

Carcinoma, Hepatocellular

Thailand
Allievex Corporation

Completed

A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)

Mucopolysaccharidosis Type IIIB | Mucopolysaccharidosis Type 3 B | MPS III B | MPS 3 B

United States, Spain, Turkey, Taiwan, Australia, Colombia, Germany, United Kingdom
Memorial Sloan Kettering Cancer Center
Chugai Pharma USA

Recruiting

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Primary Extra-cranial Solid Tumor | Recurrent or Refractory Glypican 3 (GPC3)

United States
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Sir Run Run Shaw Hospital

Completed

Clinical Study of T Cell Infusion Targeting BCMA Chimeric Antigen Receptor

Multiple Myeloma

China
Hadassah Medical Organization
DIABETES UNIT

Unknown

Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)

Giving a Vaccination in Three Months
Population Health Research Institute

Completed

Heart Outcomes Prevention Evaluation-3 (HOPE-3)

Stroke | Cardiovascular Disease

Canada
Health Science Center of Xi'an Jiaotong University
Shanghai Jiao Tong University School of Medicine

Completed

Adiponectin and Insulin Resistance in Diabetic Nephropathy

Diabetic Nephropathy

China
Innovative Medical

Unknown

Evaluation of Visual Outcomes of Monovision Patients Bilaterally Implanted With Nanoflex Intraocular Lenses

Patients Who Have Bilateral NanoFlex Implantation at Least 3 Months Previously

United States
MedImmune LLC

Completed

Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children

Healthy

United States
Possible
Nyaya Health Nepal; Ministry of Health and Population, Nepal

Withdrawn

Integrated NCD Intervention in Rural Nepal

Hypertension | Diabetes Mellitus, Type 2 | Chronic Obstructive Pulmonary Disease | Noncommunicable Diseases

Nepal
Solvay Pharmaceuticals

Completed

Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia

Diabetes Mellitus, Type 2 | Dyslipidemia

France
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Enrolling by invitation

Long Term Extension Study in Patients With Primary Hyperoxaluria (PHYOX3)

Kidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)

United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
aTyr Pharma, Inc.
Kyorin Pharmaceutical Co.,Ltd

Recruiting

Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States, Japan, Netherlands, Spain, United Kingdom, France, Italy, Brazil, Germany, Puerto Rico
Faculty Hospital Kralovske Vinohrady

Completed

a Retrospective Observational Study Comparing Outcomes of Retrocaecal Appendicitis With Non-retrocaecal Appendicitis

Appendicitis | Appendicitis Acute | Retrocecal Appendicitis

Czechia
MEDA Pharma GmbH & Co. KG

Completed

Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

Actinic Keratosis

France
Azitra Inc.
RCTs

Completed

Safety Study of AZT-04 for Cosmetic Use

Study of Three Doses of AZT-04 for Skin Appearance

United States
Fondazione Angelo Bianchi Bonomi
Sintesi Research Srl

Active, not recruiting

Type 3 Von Willebrand International Registries Inhibitor Prospective Study (3WINTERSIPSEXT)

Type 3 Von Willebrand's Disease

Finland, France, Germany, Hungary, Iran, Islamic Republic of, Italy, Netherlands, Spain, Sweden, United Kingdom
3-D Matrix Europe SAS

Completed

IEIK13 For Neurosurgery

Oozing (Hemorrhage) During Intracranial Procedures

Belgium
3-D Matrix Europe SAS

Completed

Post-market Clinical Study to Confirm Safety and Performance of PuraStat® for the Management of Bleeding in Vascular Surgery.

Vascular Anastomosis Surgery

United Kingdom
Vera Therapeutics, Inc.

Recruiting

Atacicept in Subjects With IgA Nephropathy (ORIGIN 3)

IgA Nephropathy | Berger Disease

United States
Solvay Pharmaceuticals

Terminated

Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study

Type 2 Diabetes | Dyslipidemia

Finland, Ireland, Italy
Cairo University
Norhan Abdel Aleem Ali; Hagar hassanein refaee; Ahmed Abdullah Fathi Mohamed...

Completed

A Comparative Study on Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl for Optimal Dose to be Used in Elderly Patients Undergoing Day Case Lower Abdominal and Urologic Surgeries.

Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl

Egypt
Central Department of Public Health
Harvard School of Public Health (HSPH)

Not yet recruiting

Effectiveness and Adoption of the TelTex4BP Intervention Among Adults With Hypertension in Nepal (TelTex4BP)

Cardiovascular Diseases | Hypertension | Blood Pressure | Medication Adherence

Nepal
Charles University, Czech Republic
Faculty Hospital Kralovske Vinohrady

Completed

Celecoxib in Postoperative Analgesia for Radius Fracture Surgery

Pain, Postoperative

Czechia
Clinique Pasteur

Completed

Patient Blood Management in Cardiac Surgery (PBMc)

Surgical Blood Loss

France
Insamlingsstiftelsen Wonsa, World of No Sexual...
Karolinska Institutet

Completed

Lifespan Integration After Sexual Trauma

Symptoms of Post Traumatic Stress Disorder (PTSD)

Sweden
Achieve Life Sciences

Completed

Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Russian Federation
SignPath Pharma, Inc.

Completed

A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer

Patients w/Advanced Cancer That Failed Std of Care Therapy

Austria
Baxter Healthcare Corporation

Completed

Comparison of the Impact of Dialysis Treatment Type on Patient Survival

End Stage Renal Disease

China
Azienda Sanitaria Locale 3, Torino

Completed

Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences

Pericarditis

Italy
Coloplast A/S

Completed

Safety and Performance of New 1-piece Ostomy Product

Stoma Ileostomy

Denmark
Wael Elbanna Clinic
Fetal Medicine Research Center, Spain

Recruiting

Comparison Between Biopsied and Non-biopsied Intracytoplasmatic Sperm Injection (ICSI) Embryos and Natural Pregnancy Embryos (BNB-ICSI)

Women Conceiving by: 1- ICSI-PGS 2- ICSI-non-PGS 3- Spontaneously Conceiving Women

Egypt
University of Talca
Universidad de los Andes, Chile

Not yet recruiting

Early Development of Academic Skills in the Classroom (JAPI)

General Population of Children Aged 3 to 5 Years Old
Dicerna Pharmaceuticals, Inc.

Completed

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients (PHYOX4)

Primary Hyperoxaluria Type 3

United States, Germany, Netherlands, United Kingdom
Astellas Pharma Inc

Completed

Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

Dermatitis, Atopic

France, United Kingdom, Spain, Belgium, Portugal, Netherlands, Finland, Czech Republic, Germany, Hungary, Italy
National Cancer Institute (NCI)
Celgene Corporation

Active, not recruiting

Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma

Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditions

United States
National Cancer Institute (NCI)

Completed

Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditions

United States
Tris Pharma, Inc.

Completed

Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic

Diabetic Polyneuropathy

Germany, United Kingdom
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco; Associazione Culturale Pediatri

Completed

Efficacy of Nebulised Beclometasone in Viral Wheezing Prophylaxis (ENBe)

Respiratory Tract Infections | Respiratory Sounds | Bronchial Spasm

Italy
National Taiwan University Hospital

Completed

Quality Improvement Intervention to Promote Early Mobilization in Trauma ICU

Patients Admitted to the ICU More Than 3 Days Post-onset

Taiwan

Search clinical trials for: Primary Hyperoxaluria Type 3

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations